000 | 01206 a2200313 4500 | ||
---|---|---|---|
005 | 20250515233741.0 | ||
264 | 0 | _c20101021 | |
008 | 201010s 0 0 jpn d | ||
022 | _a0917-5857 | ||
024 | 7 |
_aCliCa100812451252 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTanaka, Hiroyuki | |
245 | 0 | 0 |
_a[Genetic basis for skeletal disease. Osteogenesis imperfecta]. _h[electronic resource] |
260 |
_bClinical calcium _cAug 2010 |
||
300 |
_a1245-52 p. _bdigital |
||
500 | _aPublication Type: English Abstract; Journal Article; Review | ||
650 | 0 | 4 |
_aBone Density Conservation Agents _xadministration & dosage |
650 | 0 | 4 |
_aDiphosphonates _xadministration & dosage |
650 | 0 | 4 | _aEvidence-Based Dentistry |
650 | 0 | 4 |
_aFractures, Bone _xetiology |
650 | 0 | 4 |
_aHuman Growth Hormone _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfusions, Intravenous |
650 | 0 | 4 |
_aOsteogenesis Imperfecta _xdrug therapy |
650 | 0 | 4 |
_aParathyroid Hormone _xadministration & dosage |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
773 | 0 |
_tClinical calcium _gvol. 20 _gno. 8 _gp. 1245-52 |
|
856 | 4 | 0 |
_uhttps://doi.org/CliCa100812451252 _zAvailable from publisher's website |
999 |
_c20015249 _d20015249 |